A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported.
from Latest Science News -- ScienceDaily http://ift.tt/1OmRZeO via Karis World
from Latest Science News -- ScienceDaily http://ift.tt/1OmRZeO via Karis World
No comments:
Post a Comment